scAAV1.tMCK.NTF3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for scAAV1.tMCK.NTF3, covering 2025-06-24 to 2025-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A [Phase 1, Phase 2]